E3 ligase ligand optimization of Clinical PROTACs

Overview of attention for article published in Frontiers in Chemistry, January 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (56th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 28 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 9,104 followers.

RT @Trankill34: E3 ligase ligand optimization of Clinical PROTACs 👌https://t.co/ckLifBKa2V

04 Feb 2023

Reply Repost Favourite

RT @Trankill34: E3 ligase ligand optimization of Clinical PROTACs 👌https://t.co/ckLifBKa2V

04 Feb 2023

Reply Repost Favourite

E3 ligase ligand optimization of Clinical PROTACs 👌https://t.co/ckLifBKa2V

03 Feb 2023

Reply Repost Favourite

New Research: E3 ligase ligand optimization of Clinical PROTACs: Proteolysis targeting chimeras (PROTACs) technology can realize the development of drugs for non-druggable targets that are difficult to achieve with traditional small molecules,… https://t.c

17 Jan 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.